Squarepoint Ops LLC Immunic, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.98 - $1.44 $9,084 - $13,348	-9,270 Reduced 29.59%	22,054 $24,000
Q1 2024 May 15, 2024	BUY	$1.14 - $1.53 $35,709 - $47,925	31,324 New	31,324 $41,000
Q1 2021 May 17, 2021	SELL	$14.21 - $25.3 $591,732 - $1.05 Million	-41,642 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.8 - $20.37 $258,245 - $355,436	17,449 Added 72.12%	41,642 $637,000
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $284,025 - $532,246	24,193 New	24,193 $449,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.6M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.